Report highlights Elanco&#39;s impact through innovation, expanded access to animal care, a stronger and more sustainable food system and investment in people and communitiesINDIANAPOLIS, July 31, 2026 /PRNewswire/ --

Report highlights Elanco&#39;s impact through innovation, expanded access to animal care, a stronger and more sustainable food system and investment in people and communitiesINDIANAPOLIS, July 31, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/ELAN">ELAN</a>) today released its 2025 Impact Report, &#34;Leading with Purpose,&#34; highlighting how the company brings together purpose, innovation and business strategy to help address some of society&#39;s most pressing challenges.
 <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 
 <img xmlns="http://www.w3.org/1999/xhtml" src="https://mmx.prnewswire.com/media/MS653209/Elanco-Logo.jpg?id=OA2818607" title="Elanco logo" alt="Elanco logo"></img>
 
 </div>
The report details Elanco&#39;s progress across four interconnected areas: going beyond for animals, customers, society and its people. Together, these priorities demonstrate how Elanco can help animals live healthier, more active lives; support farmers and veterinarians; strengthen the global food supply; and contribute to healthier, more resilient communities.&#34;Animals are at the center of two of society&#39;s most fundamental needs: nutritious food and meaningful companionship,&#34; said Jeff Simmons, president and CEO of Elanco. &#34;As demand for both continues to grow, animal health has never been more important. Elanco and our industry help pets live longer, healthier lives while enabling farmers to produce safe, affordable and sustainable protein. By connecting our purpose with our strategy, we put impact at the heart of how we innovate and help address some of the world&#39;s most pressing challenges.&#34;Report Highlights Elanco&#39;s achievements highlighted in the report include:Going Beyond for Animals<ul xmlns="http://www.w3.org/1999/xhtml" type="circle"><li xmlns="http://www.w3.org/1999/xhtml">Generated $892 million in 2025 revenue from new innovation, led by products including Credelio Quattro, Zenrelia, Experior and AdTab. </li><li xmlns="http://www.w3.org/1999/xhtml">Progressed Elanco&#39;s next wave of innovation, including 5-6 blockbuster-potential approvals by 2031, with unprobabilized potential peak sales value of more than $2 billion – effectively doubling the value of the last wave. </li><li xmlns="http://www.w3.org/1999/xhtml">Established Credelio Quattro as Elanco&#39;s fastest pet health blockbuster and one of the fastest in the animal health industry. </li><li xmlns="http://www.w3.org/1999/xhtml">Helped treat more than two million itchy dogs worldwide to date with Zenrelia. </li><li xmlns="http://www.w3.org/1999/xhtml">Secured emergency and conditional regulatory authorizations to help protect pets and livestock from New World screwworm, an emerging pest that can infest any warm-blooded animals – including livestock and pets. </li><li xmlns="http://www.w3.org/1999/xhtml">Supported more than 1,000 animal shelters and rescue organizations through Paws for Purpose+ and expanded partnerships with IndyHumane and Medical Mutts Service Dogs.</li></ul>Going Beyond for Customers<ul xmlns="http://www.w3.org/1999/xhtml" type="circle"><li xmlns="http://www.w3.org/1999/xhtml">Helped feedyards measure, quantify and monetize carbon-reduction interventions for more than 1.4 million cattle in 2025, resulting in more than 200,000 metric tons of CO₂e reductions. </li><li xmlns="http://www.w3.org/1999/xhtml">Expanded the use of science-based products and digital tools, including Bovaer, Experior, Rumensin, Zimprova and UpLook, to help producers improve efficiency and environmental sustainability. </li><li xmlns="http://www.w3.org/1999/xhtml">Continued investing in the wellbeing and development of veterinarians through mental health resources, professional education, fellowships and global academic partnerships.</li></ul>Going Beyond for Society<ul xmlns="http://www.w3.org/1999/xhtml" type="circle"><li xmlns="http://www.w3.org/1999/xhtml">Advanced food safety through a global Salmonella control program operating in 23 countries. </li><li xmlns="http://www.w3.org/1999/xhtml">Promoted responsible antimicrobial use through industry-leading stewardship initiatives and global partnerships. </li><li xmlns="http://www.w3.org/1999/xhtml">Launched Nutrition Secure Indy, providing animal protein, produce, milk and eggs to 250 Indianapolis families while studying the connection between nutrition access and health and community outcomes. </li><li xmlns="http://www.w3.org/1999/xhtml">Opened Elanco&#39;s new global headquarters as the anchor of the One Health Innovation District, created in partnership with Purdue University to accelerate collaboration across animal, human and plant health. </li><li xmlns="http://www.w3.org/1999/xhtml">Strengthened product and consumer safety by recovering more than 160,000 counterfeit products valued at over $13 million.</li></ul>Going Beyond for Our People<ul xmlns="http://www.w3.org/1999/xhtml" type="circle"><li xmlns="http://www.w3.org/1999/xhtml">Achieved an employee engagement score of 73%, 4 percentage points above the external benchmark. </li><li xmlns="http://www.w3.org/1999/xhtml">Expanded employee ownership through a new ownership award program and strengthened an ownership mindset through Ascend. </li><li xmlns="http://www.w3.org/1999/xhtml">Invested in leadership development through the launch of Leader 2030 and other programs focused on building the workforce of the future. </li><li xmlns="http://www.w3.org/1999/xhtml">Mobilized employees to contribute more than 28,000 volunteer hours, with 22.6% employee participation, supporting 938 nonprofit organizations worldwide.</li></ul>The report also outlines Elanco&#39;s governance and responsible business practices, including its approach to product quality and safety, animal welfare, environmental resilience, employee health and safety, ethical conduct and oversight of environmental, social and governance-related risks and opportunities.&#34;Our people bring our purpose to life every day, in laboratories, manufacturing sites, veterinary clinics, farms, communities and homes,&#34; Simmons said. &#34;The progress reflected in this report demonstrates what is possible when innovation, customer value and purpose work together to improve the health of animals and the lives of the people who depend on them.&#34;The complete 2025 Elanco Impact Report and supporting environmental, social and governance disclosures are <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743037-1&amp;h=3772146602&amp;u=https%3A%2F%2Fassets.elanco.com%2F63faca97-0277-00f3-7b39-47b486080a51%2Ffb763fb6-4bd7-463b-ab94-f5e2fdeda2aa%2FElanco%2520FY25%2520Impact%2520Report%2520FINAL.pdf&amp;a=available+here" target="_blank" rel="nofollow">available here</a>.ABOUT ELANCO Elanco Animal Health Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/ELAN">ELAN</a>) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. Learn more at <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743037-1&amp;h=1366689440&amp;u=https%3A%2F%2Fwww.elanco.com%2F&amp;a=www.elanco.com" rel="nofollow">www.elanco.com</a>.Investor Contact: Tiffany Kanaga (765) 740-0314 <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:tiffany.kanaga@elancoah.com" rel="nofollow">tiffany.kanaga@elancoah.com</a> Media Contact: Colleen Parr Dekker (317) 989-7011 <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:colleen.dekker@elancoah.com" target="_blank" rel="nofollow">colleen.dekker@elancoah.com</a>



<img xmlns="http://www.w3.org/1999/xhtml" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=DE16445&amp;sd=2026-07-31"></img> View original content to download multimedia:<a xmlns="http://www.w3.org/1999/xhtml" id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/elanco-releases-2025-impact-report-demonstrating-how-animal-health-helps-meet-societys-growing-needs-302839584.html" target="_blank">https://www.prnewswire.com/news-releases/elanco-releases-2025-impact-report-demonstrating-how-animal-health-helps-meet-societys-growing-needs-302839584.html</a>SOURCE Elanco Animal Health

ELAN

Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs

Elanco 2025 Impact Report highlights $892M revenue and 2031 pipeline upside

<section class="insight" data-version="1">
 <section data-block="information">
 <h3>Information</h3>
 Report highlights Elanco&amp;#39;s impact through innovation, expanded access to animal care, a stronger and more sustainable food system and investment in people and communitiesINDIANAPOLIS, July 31, 2026 /PRNewswire/ --
 </section>

 <section data-block="ai-summary-paragraph">
 <h3>AI Summary</h3>
 Elanco released its 2025 Impact Report, declaring progress across animals, customers, society and people. The document highlights $892 million in 2025 revenue from new innovations and a 2031 pipeline of 5–6 blockbuster approvals with potential peak sales above $2 billion, underpinning a long-term growth and ESG-driven valuation narrative.
 </section>

 <section data-block="ai-summary-bullets">
 <h3>Key Points</h3>
 <ul><li>Elanco releases 2025 Impact Report outlining progress across four priority areas.</li><li>2025 innovation revenue reached $892 million; 2031 pipeline targets 5–6 approvals and &gt;$2B peak.</li><li>Credelio Quattro is Elanco&#039;s fastest pet-health blockbuster; Zenrelia treated &gt;2M itchy dogs.</li><li>Regulatory authorizations for New World screwworm advance animal protection.</li><li>HQ opened at One Health Innovation District with Purdue; CO2e, food safety and societal initiatives highlighted.</li></ul>
 </section>

 <section data-block="companies-mentioned">
 <h3>Companies Mentioned</h3>
 <ul><li>Elanco Animal Health Incorporated (ELAN): Releases 2025 Impact Report; highlights pipeline, ESG initiatives and revenue milestones.</li><li>Purdue University (NA): Partner in One Health Innovation District; collaboration to accelerate cross-disciplinary health research.</li><li>IndyHumane (NA): Expanded partnerships for shelter support tied to Elanco&#039;s community initiatives.</li><li>Medical Mutts Service Dogs (NA): Expanded partnerships as part of Elanco&#039;s animal welfare outreach.</li></ul>
 </section>

 <section data-block="category">
 <h3>Corporate Developments</h3>
 Category: Corporate Developments. The release centers on ESG-aligned corporate strategy and pipeline progress, signaling longer-term valuation catalysts rather than immediate quarterly performance.
 </section>

 <section data-block="market-moving">
 <h3>Market-Moving</h3>
 <ul><li>2025 innovation revenue reached $892 million; 5–6 potential approvals by 2031 could exceed $2B at peak.</li><li>Credelio Quattro fastest pet-health blockbuster; Zenrelia has treated &gt;2 million itchy dogs.</li><li>1.4 million cattle carbon interventions in 2025, delivering &gt;200,000 metric tons CO2e reductions.</li><li>23-country Salmonella control program and ongoing antimicrobial stewardship enhancements.</li><li>New global HQ opened in the One Health Innovation District in partnership with Purdue.</li></ul>
 </section>

 <section data-block="key-facts">
 <h3>Key Facts</h3>
 <ul><li>2025 innovation revenue: $892 million.</li><li>5–6 blockbuster-potential approvals by 2031; unprobabilized peak sales &gt;$2 billion.</li><li>Credelio Quattro established as Elanco&#039;s fastest pet-health blockbuster.</li><li>Zenrelia: &gt;2,000,000 itchy dogs treated to date.</li><li>1.4 million cattle carbon-reduction interventions in 2025; &gt;200,000 metric tons CO2e reductions.</li><li>Salmonella control program active in 23 countries; &gt;$13 million value of 160,000 counterfeit products recovered.</li><li>Elanco opened its new global HQ as anchor of One Health Innovation District with Purdue.</li></ul>
 </section>

 <section data-block="trading-thesis">
 <h3>Trading Thesis</h3>
 Bullish over 12–24 months as pipeline upside and ESG momentum support valuation.
 </section>
</section>


Report highlights Elanco&#39;s impact through innovation, expanded access to animal care, a stronger and more sustainable food system and investment in people and communitiesINDIANAPOLIS, July 31, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/ELAN">ELAN</a>) today released its 2025 Impact Report, &#34;Leading with Purpose,&#34; highlighting how the company brings together purpose, innovation and business strategy to help address some of society&#39;s most pressing challenges.
 <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 
 <img xmlns="http://www.w3.org/1999/xhtml" src="https://mmx.prnewswire.com/media/MS653209/Elanco-Logo.jpg?id=OA2818607" title="Elanco logo" alt="Elanco logo"></img>
 
 </div>
The report details Elanco&#39;s progress across four interconnected areas: going beyond for animals, customers, society and its people. Together, these priorities demonstrate how Elanco can help animals live healthier, more active lives; support farmers and veterinarians; strengthen the global food supply; and contribute to healthier, more resilient communities.&#34;Animals are at the center of two of society&#39;s most fundamental needs: nutritious food and meaningful companionship,&#34; said Jeff Simmons, president and CEO of Elanco. &#34;As demand for both continues to grow, animal health has never been more important. Elanco and our industry help pets live longer, healthier lives while enabling farmers to produce safe, affordable and sustainable protein. By connecting our purpose with our strategy, we put impact at the heart of how we innovate and help address some of the world&#39;s most pressing challenges.&#34;Report Highlights Elanco&#39;s achievements highlighted in the report include:Going Beyond for Animals<ul xmlns="http://www.w3.org/1999/xhtml" type="circle"><li xmlns="http://www.w3.org/1999/xhtml">Generated $892 million in 2025 revenue from new innovation, led by products including Credelio Quattro, Zenrelia, Experior and AdTab. </li><li xmlns="http://www.w3.org/1999/xhtml">Progressed Elanco&#39;s next wave of innovation, including 5-6 blockbuster-potential approvals by 2031, with unprobabilized potential peak sales value of more than $2 billion – effectively doubling the value of the last wave. </li><li xmlns="http://www.w3.org/1999/xhtml">Established Credelio Quattro as Elanco&#39;s fastest pet health blockbuster and one of the fastest in the animal health industry. </li><li xmlns="http://www.w3.org/1999/xhtml">Helped treat more than two million itchy dogs worldwide to date with Zenrelia. </li><li xmlns="http://www.w3.org/1999/xhtml">Secured emergency and conditional regulatory authorizations to help protect pets and livestock from New World screwworm, an emerging pest that can infest any warm-blooded animals – including livestock and pets. </li><li xmlns="http://www.w3.org/1999/xhtml">Supported more than 1,000 animal shelters and rescue organizations through Paws for Purpose+ and expanded partnerships with IndyHumane and Medical Mutts Service Dogs.</li></ul>Going Beyond for Customers<ul xmlns="http://www.w3.org/1999/xhtml" type="circle"><li xmlns="http://www.w3.org/1999/xhtml">Helped feedyards measure, quantify and monetize carbon-reduction interventions for more than 1.4 million cattle in 2025, resulting in more than 200,000 metric tons of CO₂e reductions. </li><li xmlns="http://www.w3.org/1999/xhtml">Expanded the use of science-based products and digital tools, including Bovaer, Experior, Rumensin, Zimprova and UpLook, to help producers improve efficiency and environmental sustainability. </li><li xmlns="http://www.w3.org/1999/xhtml">Continued investing in the wellbeing and development of veterinarians through mental health resources, professional education, fellowships and global academic partnerships.</li></ul>Going Beyond for Society<ul xmlns="http://www.w3.org/1999/xhtml" type="circle"><li xmlns="http://www.w3.org/1999/xhtml">Advanced food safety through a global Salmonella control program operating in 23 countries. </li><li xmlns="http://www.w3.org/1999/xhtml">Promoted responsible antimicrobial use through industry-leading stewardship initiatives and global partnerships. </li><li xmlns="http://www.w3.org/1999/xhtml">Launched Nutrition Secure Indy, providing animal protein, produce, milk and eggs to 250 Indianapolis families while studying the connection between nutrition access and health and community outcomes. </li><li xmlns="http://www.w3.org/1999/xhtml">Opened Elanco&#39;s new global headquarters as the anchor of the One Health Innovation District, created in partnership with Purdue University to accelerate collaboration across animal, human and plant health. </li><li xmlns="http://www.w3.org/1999/xhtml">Strengthened product and consumer safety by recovering more than 160,000 counterfeit products valued at over $13 million.</li></ul>Going Beyond for Our People<ul xmlns="http://www.w3.org/1999/xhtml" type="circle"><li xmlns="http://www.w3.org/1999/xhtml">Achieved an employee engagement score of 73%, 4 percentage points above the external benchmark. </li><li xmlns="http://www.w3.org/1999/xhtml">Expanded employee ownership through a new ownership award program and strengthened an ownership mindset through Ascend. </li><li xmlns="http://www.w3.org/1999/xhtml">Invested in leadership development through the launch of Leader 2030 and other programs focused on building the workforce of the future. </li><li xmlns="http://www.w3.org/1999/xhtml">Mobilized employees to contribute more than 28,000 volunteer hours, with 22.6% employee participation, supporting 938 nonprofit organizations worldwide.</li></ul>The report also outlines Elanco&#39;s governance and responsible business practices, including its approach to product quality and safety, animal welfare, environmental resilience, employee health and safety, ethical conduct and oversight of environmental, social and governance-related risks and opportunities.&#34;Our people bring our purpose to life every day, in laboratories, manufacturing sites, veterinary clinics, farms, communities and homes,&#34; Simmons said. &#34;The progress reflected in this report demonstrates what is possible when innovation, customer value and purpose work together to improve the health of animals and the lives of the people who depend on them.&#34;The complete 2025 Elanco Impact Report and supporting environmental, social and governance disclosures are <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743037-1&amp;h=3772146602&amp;u=https%3A%2F%2Fassets.elanco.com%2F63faca97-0277-00f3-7b39-47b486080a51%2Ffb763fb6-4bd7-463b-ab94-f5e2fdeda2aa%2FElanco%2520FY25%2520Impact%2520Report%2520FINAL.pdf&amp;a=available+here" target="_blank" rel="nofollow">available here</a>.ABOUT ELANCO Elanco Animal Health Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/ELAN">ELAN</a>) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. Learn more at <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743037-1&amp;h=1366689440&amp;u=https%3A%2F%2Fwww.elanco.com%2F&amp;a=www.elanco.com" rel="nofollow">www.elanco.com</a>.Investor Contact: Tiffany Kanaga (765) 740-0314 <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:tiffany.kanaga@elancoah.com" rel="nofollow">tiffany.kanaga@elancoah.com</a> Media Contact: Colleen Parr Dekker (317) 989-7011 <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:colleen.dekker@elancoah.com" target="_blank" rel="nofollow">colleen.dekker@elancoah.com</a>



<img xmlns="http://www.w3.org/1999/xhtml" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=DE16445&amp;sd=2026-07-31"></img> View original content to download multimedia:<a xmlns="http://www.w3.org/1999/xhtml" id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/elanco-releases-2025-impact-report-demonstrating-how-animal-health-helps-meet-societys-growing-needs-302839584.html" target="_blank">https://www.prnewswire.com/news-releases/elanco-releases-2025-impact-report-demonstrating-how-animal-health-helps-meet-societys-growing-needs-302839584.html</a>SOURCE Elanco Animal Health

Elanco released its 2025 Impact Report, declaring progress across animals, customers, society and people. The document highlights $892 million in 2025 revenue from new innovations and a 2031 pipeline of 5–6 blockbuster approvals with potential peak sales above $2 billion, underpinning a long-term growth and ESG-driven valuation narrative.

News insight

Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs

AI summary

Sentiment rationale

Key facts

Corporate Developments